Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice

Laboratory Investigation

Volumn 76, Issue 3, 1997, Pages 339-353

  Lamszus, Katrin ^a   Jin, Liang ^a   Fuchs, Alexander ^a   Shi, Eric ^a   Chowdhury, Soheli ^a   Yao, Yan ^a   Polverini, Peter J ^b   Laterra, John ^c   Goldberg, Itzhak D ^a   Rosen, Eliot M ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CYCLINE; DNA NUCLEOTIDYLEXOTRANSFERASE; GLYCOPROTEIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; SCATTER FACTOR; THROMBOSPONDIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CELL CULTURE; CELL CLONE; CELL INVASION; CELL MOTILITY; CHEMOTAXIS; COLONY FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR GROWTH; TUMOR VASCULARIZATION;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CELL DIVISION; CLONE CELLS; CORNEA; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; KINETICS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MICE, NUDE; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MET; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030904579     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, and Aaronson SA (1991). Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science 251:802-804.
2. Gavrieli Y, Sherman Y, and Ben-Sasson SA (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
3. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, and Bouck NP (1990). A tumor supressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628.
4. Grant DS, Kleinman HK, Goldberg ID, Bhargava M, Nickoloff BJ, Polverini P, and Rosen EM (1993). Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90:1937-1941.
5. Haran EF, Maretzek AF, Goldberg I, Horowitz A, and Degani H (1994). Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res 54:5511-5514.
6. Holmgren L, O'Reilly MS, and Folkman J (1995). Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149-153.
7. Huff JL, Jelinek MA, Jamieson TA, and Parsons JT (1996). Expression and maturation of cellular sea receptor, a member of the hepatocyte growth factor (HGF) receptor family of protein tyrosine kinases. Oncogene 12:299-307.
8. Joseph A, Weiss GH, Jin L, Fuchs A, Chowdhury S, O'Shaughnessy P, Goldberg ID, and Rosen EM (1995). Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst 87:372-377.
9. Kern FG, McLeskey SW, Zhang L, Kurebayashi J, Liu Y, Ding IY, Kharbanda S, Chen D, Miller D, Cullen K, Paik S, and Dickson RB (1994). Transfected MCF-7 cells as a model for breast cancer progression. Breast Cancer Res Treat 31:153-165.
10. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, and Ferrara N (1994). Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149-4156.
11. Leone A, Flatow U, VanHoutte K, and Steeg PS (1993). Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization, and enzymatic activity. Oncogene 8:2325-2333.
12. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, and Shimizu S (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443.
13. O'Reilly MS, Holmgren L, Chen C, and Folkman J (1996). Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 2:689-692.
14. Polverini PJ and Leibovich SJ (1984). Induction of neovascularization in vivo and endothelial cell proliferation in vivo by tumor-associated macrophages. Lab Invest 51:635-642.
15. Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, Chan A, Aaronson S, and Vande Woude GF (1992). Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 12:5152-5158.
16. Rosen EM and Goldberg ID (1995). Scatter factor and angiogenesis. Adv Cancer Res 67:257-279.
17. Rosen EM, Goldberg ID, Liu D, Setter E, Donovan MA, Bhargava M, Reiss M, and Kacinski BM (1991). Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res 57:5315-5321.
18. Rosen EM, Joseph A, Jin L, Rockwell S, Elias JA, Knesel J, Wines J, McClellan J, Kluger MJ, Goldberg ID, and Zitnik R (1994c). Regulation of scatter factor production via a soluble inducing factor. J Cell Biol 127:225-234.
19. Rosen EM, Knesel J, Goldberg ID, Bhargava M, Joseph A, Zitnik R, Wines J, Kelley M, and Rockwell S (1994b). Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer 57:706-714.
20. Rosen EM, Meromsky L, Setter E, Vinter DW, and Goldberg ID (1990). Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis 10:49-64.
21. Rosen EM, Nigam SK, and Goldberg ID (1994a). Scatter factor and the c-met receptor: A paradigm for mesenchymal/ epithelial interaction. J Cell Biol 127:1783-1787.
22. Stoker M, Gherardi E, Perryman M, and Gray J (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327:238-242.
23. Takasaki Y, Deng JS, and Tan EM (1981). A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med 154:1899-1909.
24. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, and Bouck N (1993). Peptides derived from two separate domains of the matrix protein thrombospondin-1 have antiangiogenic activity. J Cell Biol 122:497-511.
25. Tuck AB, Park M, Sterns EE, Boag A, and Elliott BE (1996). Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol 148:225-232.
26. Wang M-H, Ronsin C, Gesnel M-C, Coupey L, Skeel A, Leonard EJ, and Breathnach R (1994). Identification of the ron gene product as the receptor for human macrophage stimulating protein. Science 266:117-119.
27. Wang Y, Selden AC, Morgan N, Stamp GW, and Hodgson HJ (1994). Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol 144:675-682.
28. Weidner KM, Behrens J, Vandekerckhove J, and Birchmeier W (1990). Scatter factor: Molecular characteristics and effect on invasiveness of epithelial cells. J Cell Biol 111:2097-2108.
29. Weidner N, Folkman J, Pozza F, Bevilaqua P, Allred EN, Moore DH, Meli S, and Gasparini G (1992). Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 84:1875-1887.
30. Weidner N, Sample JP, Welch WR, and Folkman J (1991). Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 324:1-8.
31. Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD, and Steeg PS (1994). Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54:6504-6511.
32. Wolff JEA, Guerin C, Laterra J, Bressler J, Indurati RR, Brem H, and Goldstein GW (1993). Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors. Brain Res 604:79-85.
33. Wyllie AH (1992). Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metastasis Rev 11:95-103.
34. Yamashita J, Ogawa M, and Beppu T (1993). Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer ceil lines. Res Commun Chem Pathol Pharmacol 82:249-252.
35. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T, and Sadahito S (1994). Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54:1630-1633.
36. Yao Y, Jin L, Fuchs A, Joseph A, Hastings H, Goldberg ID, and Rosen EM (1996). Scatter factor protein levels in human breast cancers: Clinicopathologic and biologic correlations. Am J Pathol 149:1707-1717.
37. Yoshimura T, Yuhki N, Wang MH, Skeel A, and Leonard EJ (1993). Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J Biol Chem 268:15461-15468.